Interise Trust reports consolidated net loss of Rs 53.20 crore in the March 2026 quarter

April 29, 2026 · 9:06 am IST Source: Business Standard
๐Ÿ“Œ

Key Takeaways

  • Sales rose 2.97% to Rs 906.35 crore in the quarter ended March 2026 as against Rs 880.23 crore during the previous quarter ended March 2025.
  • Sales rose 2.61% to Rs 3566.87 crore in the year ended March 2026 as against Rs 3476.17 crore during the previous year ended March 2025.
  • Sales rise 2.97% to Rs 906.35 crore Net loss of Interise Trust reported to Rs 53.20 crore in the quarter ended March 2026 as against net profit of Rs 54.79 crore during the previous quarter ended March 2025.
  • For the full year,net profit reported to Rs 42.15 crore in the year ended March 2026 as against net loss of Rs 71.40 crore during the previous year ended March 2025.

Full Report

Sales rise 2.97% to Rs 906.35 crore
Net loss of Interise Trust reported to Rs 53.20 crore in the quarter ended March 2026 as against net profit of Rs 54.79 crore during the previous quarter ended March 2025. Sales rose 2.97% to Rs 906.35 crore in the quarter ended March 2026 as against Rs 880.23 crore during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 42.15 crore in the year ended March 2026 as against net loss of Rs 71.40 crore during the previous year ended March 2025. Sales rose 2.61% to Rs 3566.87 crore in the year ended March 2026 as against Rs 3476.17 crore during the previous year ended March 2025.

Originally reported by Business Standard.
๐Ÿ’ก

IPO Cracker Take

This market development has implications for IPO investors tracking upcoming issues. See our IPO calendar and live GMP data for the most recent moves.

โ“

Frequently Asked Questions

Market news feeds into IPO pricing decisions, subscription timing, and listing-day sentiment. Track the broader market daily alongside each active IPO's own fundamentals.

Our IPO calendar shows all upcoming, open, and recently listed issues in one place — with price band, GMP, and subscription data.

We publish daily market and IPO news, live GMP updates, and subscription tracking. Bookmark our News page or follow us on social media for real-time updates.
0 Comments

No comments yet. Be the first to share your opinion!